BAP1 and cholangiocarcinoma: We detected small somatic mutations at frequencies of 15% and 12% in BAP1 (12.5% in iCCA), ATM (8.3% in iCCA) and TP53 (8.3% in iCCA), respectively (Figure 4B), confirming their role in CCA.